BGACF OTC
BioNeutra Global Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$683K
-18.5% ▼
5Y CAGR: -25.1%
Capital Expenditures
$19K
+90.5% ▲
5Y CAGR: -52.8%
Free Cash Flow
$664K
+4.7% ▲
5Y CAGR: -20.4%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+1099.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$12M | -$4M | -$3M | -$3M | -$2M |
| Depreciation & Amort. | $2M | $2M | $1M | $1M | $1M |
| Stock-Based Comp. | $5K | $0 | $483K | $0 | $0 |
| Change in Working Capital | $11M | $3M | $777K | $2M | $2M |
| Other Non-Cash Items | $521K | $460K | $517K | $209K | $36K |
| Operating Cash Flow | $708K | $1M | $271K | $838K | $683K |
| — Investing Activities — | |||||
| Capital Expenditures | -$237K | -$76K | -$277K | -$204K | -$19K |
| Acquisitions (Net) | $0 | $50K | $0 | $6K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $516K | $0 | $0 | $0 | $0 |
| Other Investing | $422K | $2K | $0 | -$78K | -$1K |
| Investing Cash Flow | $278K | -$26K | -$277K | -$197K | -$21K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$513K | $52K | $121K | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$534K | -$387K | -$350K | -$439K | -$660K |
| Financing Cash Flow | -$2M | -$900K | -$298K | -$309K | $446K |
| Net Change in Cash | -$974K | $411K | -$95K | -$117K | $1M |
| Cash End of Period | $523K | $934K | $839K | $723K | $2M |
| Free Cash Flow | $470K | $1M | -$6K | $635K | $664K |